BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2496158)

  • 1. Evidence that Mls-2 antigens which delete V beta 3+ T cells are controlled by multiple genes.
    Pullen AM; Marrack P; Kappler JW
    J Immunol; 1989 May; 142(9):3033-7. PubMed ID: 2496158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice.
    Anderson GD; Banerjee S; Luthra HS; David CS
    J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of self-MHC and non-MHC antigens on the selection of an antigen-specific T cell receptor repertoire.
    Fry AM; Cotterman MM; Matis LA
    J Immunol; 1989 Oct; 143(8):2723-9. PubMed ID: 2477456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of self-reactive T cells in the donor-derived T cells but not in the host-derived T cells in fully allogeneic radiation chimeras. Mls-reactive T cells in allogeneic radiation chimeras.
    Ogimoto M; Yoshikai Y; Matsuzaki G; Ohga S; Matsumoto K; Nomoto K
    Thymus; 1991 Feb; 17(1):11-22. PubMed ID: 1901675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of Mls-reactive T cells in H-2-compatible but Mls-incompatible bone marrow chimeras.
    Yoshikai Y; Ogimoto M; Matsumoto K; Sakumoto M; Matsuzaki G; Nomoto K
    Eur J Immunol; 1989 Jun; 19(6):1009-13. PubMed ID: 2502418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell tolerance to self antigens in New Zealand hybrid mice with lupus-like disease.
    Kotzin BL; Kappler JW; Marrack PC; Herron LR
    J Immunol; 1989 Jul; 143(1):89-94. PubMed ID: 2786535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mlsd-defined primary mixed lymphocyte reaction: a composite response to Mlsa and Mlsc determinants.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1987 Jun; 138(12):4085-92. PubMed ID: 2438333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of T cell receptor V beta gene usage in primary mixed lymphocyte reactions: evidence for directive usage by different antigen-presenting cells and Mls-like determinants on T cell blasts.
    Larsson-Sciard EL; Spetz-Hagberg AL; Casrouge A; Kourilsky P
    Eur J Immunol; 1990 Jun; 20(6):1223-9. PubMed ID: 2142455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypes.
    Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
    J Immunol; 1990 Apr; 144(7):2506-17. PubMed ID: 2138649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell recognition of Mlsc,x determinants.
    Abromson-Leeman SR; Laning JC; Dorf ME
    J Immunol; 1988 Mar; 140(6):1726-31. PubMed ID: 3126235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II A alpha and E alpha molecules determine the clonal deletion of V beta 6+ T cells. Studies with recombinant and transgenic mice.
    Anderson GD; Banerjee S; David CS
    J Immunol; 1989 Dec; 143(11):3757-61. PubMed ID: 2531186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Mls determinants in mice exhibiting the severe combined immunodeficiency (scid) mutation or X-linked immunodeficiency (xid) defect.
    Roberts JL; Abe R; Shores EW; Singer A
    J Immunol; 1992 Sep; 149(5):1577-82. PubMed ID: 1506683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice.
    Frankel WN; Rudy C; Coffin JM; Huber BT
    Nature; 1991 Feb; 349(6309):526-8. PubMed ID: 1846948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a new minor lymphocyte stimulatory system. I. Cluster of self antigens recognized by "I-E-reactive" V beta s, V beta 5, V beta 11, and V beta 12 T cell receptors for antigen.
    Abe R; Kanagawa O; Sheard MA; Malissen B; Foo-Phillips M
    J Immunol; 1991 Aug; 147(3):739-49. PubMed ID: 1713604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell recognition of Mlsc. I. Influence of MHC gene products in Mlsc-specific T cell recognition.
    Abe R; Hodes RJ
    J Immunol; 1988 Jun; 140(12):4132-8. PubMed ID: 2453568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of minor lymphocyte stimulatory-1a antigens from T cell subsets.
    Arase N; Arase H; Takayanagi T; Mishima M; Iwabuchi K; Ogasawara K; OnoƩ K
    Immunobiology; 1995 Aug; 193(5):378-90. PubMed ID: 8522355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.